Browse studies

Find your next paid study

48 recruiting studies matching your filters

A Double-Blinded, Randomized Influenza Virus Challenge Trial of Recombinant Influenza RG-A/Arkansas/08/2020 (pH1N1) in Healthy Adults to Assess Safety and Optimal Infectious Dose

This protocol describes a clinical trial to develop and validate a Controlled Human Infection Model (CHIM) for influenza A/Arkansas/08/2020 (pH1N1). The study …

Influenza

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT07110532

Phase 2

Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of the Safety and Efficacy of BPL-1357 Against H1N1 Influenza Virus Challenge

Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from i…

InfluenzaHuman

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT07215858

CSP #2038 - COVID-19 Pharmacotherapy Effectiveness in the VA Healthcare System (COPE-VA)

The purpose of this study is to comprehensively describe the temporal and geographic utilization of COVID-19 therapies used for mild to moderate disease during…

COVID-19, SARS-CoV-2 InfectionRSVInfluenza

Estimated

~$10 – $675

VA Office of Research and DevelopmentNCT06160128

Phase 1

A Phase 1, Randomized, Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of Influenza A Group 1 and Influenza A Group 2 mRNA Chimeric Hemagglutinin Vaccine Candidates Alone and in Combination in Healthy Adults.

This is a Phase 1, randomized, controlled, dose-ranging clinical trial to assess the safety and immunogenicity of novel influenza A Group 1 and influenza A Gro…

Influenza

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT07703514

Phase 3

A Phase IIIb Multicenter, Single-arm, Open-label Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Patients With Influenza and Transmission of Influenza to Household Contacts

This study consists of two parts: Part A Surveillance and Part B Transmission. The main purpose of Part A is to evaluate the prevalence of pre-dose and treatm…

Influenza

Estimated

~$10 – $7,500

Hoffmann-La RocheNCT06094010

Phase 2

Comparison of High vs Standard Dose Influenza Vaccines in Pediatric Solid Organ Transplant Recipients

Influenza virus is a significant pathogen in pediatric solid organ transplant (SOT) recipients. However, these individuals respond poorly to standard-dose (SD)…

Immunization; InfectionTransplantation InfectionInfluenza

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT05947071

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Background: * The Laboratory of Infectious Diseases (LID) Clinical Studies Unit (CSU) enrolls healthy volunteers into clinical studies to study infectious dis…

ZikaInfluenza

Estimated

~$10 – $675

National Institute of Allergy and Infectious Diseases (NIAID)NCT01386424

Phase 3

A Phase 3 Randomized, Observer-Blind, Controlled Study to Evaluate the Clinical Efficacy of an mRNA Based Seasonal Influenza Vaccine in Older Adults ≥65 Years of Age

This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one inje…

Influenza, Human

Estimated

~$10 – $7,500

GlaxoSmithKlineNCT07805707

Phase 1

A Phase 1/2, Parallel, Observer-blind Study to Assess the Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

The study aims to evaluate an egg-based H5N8 influenza vaccine up to 3 dose levels (low, medium, and high dose) given with or without adjuvant to see if the ad…

Healthy VolunteersInfluenza

VRC 328: A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Background: Vaccines help the body learn to fight infections. Some vaccines are combined with adjuvants, which are added substances that make vaccines work be…

Influenza PreventionSeasonal Influenza

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT06863142

Observational

FLU-TIDE: A Controlled Human Influenza Transmission Study Using Naturally Infected Community Donors

The purpose of this study is to determine whether influenza A or B can be transmitted from adults with naturally acquired community influenza infection to heal…

Influenza

Estimated

~$10 – $6,250

Emory UniversityNCT07814495

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

Background: Respiratory viruses circulate throughout the year and around the globe. Wearable and sensor devices, like smartwatches, may be able to help monito…

InfluenzaRespiratory VirusCoronavirus

Estimated

~$10 – $675

National Institute of Allergy and Infectious Diseases (NIAID)NCT04772170